Ted Lystig

8.8k total citations
44 papers, 2.5k citations indexed

About

Ted Lystig is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ted Lystig has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Ted Lystig's work include Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Respiratory Support and Mechanisms (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Ted Lystig is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Respiratory Support and Mechanisms (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Ted Lystig collaborates with scholars based in United States, Sweden and Belgium. Ted Lystig's co-authors include Donald P. Tashkin, Bartolomé R. Celli, Steven Kesten, Marc Decramer, Malin Lönn, Sunil Mehra, Björn Carlsson, Lena Carlsson, Elisabet Stener‐Victorin and Agneta Holmäng and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Ted Lystig

44 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ted Lystig United States	25	1.1k	740	544	444	372	44	2.5k
Chao‐Yu Guo Taiwan	32	396 0.3×	415 0.6×	654 1.2×	562 1.3×	142 0.4×	109	3.6k
Kathryn Choon Beng Tan Hong Kong	29	875 0.8×	235 0.3×	996 1.8×	478 1.1×	70 0.2×	141	3.8k
Chiara Giannarelli United States	34	383 0.3×	418 0.6×	220 0.4×	687 1.5×	56 0.2×	88	3.1k
Bum Soon Choi South Korea	37	607 0.5×	571 0.8×	693 1.3×	1.1k 2.4×	28 0.1×	194	4.7k
José T. Real Spain	24	531 0.5×	128 0.2×	469 0.9×	462 1.0×	62 0.2×	124	2.5k
Hisashi Adachi Japan	36	644 0.6×	294 0.4×	601 1.1×	515 1.2×	27 0.1×	150	3.6k
Muhei Tanaka Japan	31	733 0.6×	201 0.3×	516 0.9×	467 1.1×	26 0.1×	106	2.7k
Petter Urdal Norway	29	680 0.6×	275 0.4×	559 1.0×	563 1.3×	19 0.1×	86	2.8k
James W. Chu United States	14	369 0.3×	159 0.2×	525 1.0×	313 0.7×	44 0.1×	27	2.0k
Jennifer K. Pai United States	23	347 0.3×	265 0.4×	698 1.3×	295 0.7×	28 0.1×	37	2.4k

Countries citing papers authored by Ted Lystig

Since Specialization

Citations

This map shows the geographic impact of Ted Lystig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Lystig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Lystig more than expected).

Fields of papers citing papers by Ted Lystig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Lystig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Lystig. The network helps show where Ted Lystig may publish in the future.

Co-authorship network of co-authors of Ted Lystig

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Lystig. A scholar is included among the top collaborators of Ted Lystig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Lystig. Ted Lystig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations

Mitchel, Jules T., Nicolle M. Gatto, John C. Laschinger, et al.. (2020). Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative. Therapeutic Innovation & Regulatory Science. 55(1). 6–18. 12 indexed citations

Gould, A. Lawrence, Ted Lystig, Yun Lu, Haoda Fu, & Haijun Ma. (2014). Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group. Therapeutic Innovation & Regulatory Science. 49(1). 65–75. 5 indexed citations

Wiens, Brian L., Ted Lystig, & Scott Berry. (2013). Recent Statistical Contributions to Medical Device Development. Therapeutic Innovation & Regulatory Science. 48(1). 90–97. 3 indexed citations

Decramer, Marc, Geert Molenberghs, Steven Kesten, et al.. (2011). Premature discontinuation during the Understanding the Potential Long-term Impacts on Function with Tiotropium (UPLIFT) study: significance to efficacy results. Respiratory Medicine. 0–0. 1 indexed citations

Hanania, Nicola A., Amir Sharafkhaneh, Bartolomé R. Celli, et al.. (2011). Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respiratory Research. 12(1). 6–6. 66 indexed citations

Sjöström, C. David, Ted Lystig, & Anna Karin Lindroos. (2011). Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study. International Journal of Obesity. 35(11). 1413–1420. 46 indexed citations

Morice, Alyn H., Bartolomé R. Celli, Steven Kesten, et al.. (2010). COPD in young patients: A pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respiratory Medicine. 104(11). 1659–1667. 64 indexed citations

Troosters, Thierry, Bartolomé R. Celli, Ted Lystig, et al.. (2010). Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT® trial. European Respiratory Journal. 36(1). 65–73. 90 indexed citations

10.

Tashkin, Donald P., Bartolomé R. Celli, Steven Kesten, et al.. (2009). EFFICACY OF TIOTROPIUM IN MEN AND WOMEN: 4-YEAR FOLLOW-UP IN THE UPLIFT TRIAL. CHEST Journal. 136(4). 24S–24S. 3 indexed citations

11.

Decramer, Marc, Bartolomé R. Celli, Steven Kesten, et al.. (2009). Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. The Lancet. 374(9696). 1171–1178. 359 indexed citations

12.

Karlsson, Cecilia, Ted Lystig, Marianne Hartford, & Björn Carlsson. (2008). Sensitivity and reproducibility of indirect calorimetry in measurement of resting metabolic rate. Drug Development Research. 69(8). 502–507. 1 indexed citations

13.

Mannerås, Louise, et al.. (2007). Continuous administration of dihydrotestosterone or letrozole to immature female rats results in polycystic ovary syndrome characteristics at adult age. 14. 1 indexed citations

14.

Lystig, Ted, et al.. (2007). Porcine Transfer Study: Virtual Reality Simulator Training Compared with Porcine Training in Endovascular Novices. CardioVascular and Interventional Radiology. 30(3). 455–461. 58 indexed citations

15.

Behre, Carl Johan, Anders Gummesson, Margareta Jernås, et al.. (2007). Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome. Metabolism. 56(8). 1022–1028. 45 indexed citations

16.

Sjöholm, Kajsa, Jenny Palming, Ted Lystig, et al.. (2006). The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease. Biochemical and Biophysical Research Communications. 344(4). 1308–1314. 46 indexed citations

17.

Lystig, Ted, et al.. (2006). Assessment of a Virtual Interventional Simulator Trainer. Journal of Endovascular Therapy. 13(2). 237–243. 37 indexed citations

18.

Sjöholm, Kajsa, Jenny Palming, Louise E. Olofsson, et al.. (2005). A Microarray Search for Genes Predominantly Expressed in Human Omental Adipocytes: Adipose Tissue as a Major Production Site of Serum Amyloid A. The Journal of Clinical Endocrinology & Metabolism. 90(4). 2233–2239. 132 indexed citations

19.

Larsson, Ingrid, Anna‐Karin Lindroos, Ted Lystig, Ingmar Näslund, & Lars Sjöström. (2005). Three Definitions of the Metabolic Syndrome: Relations to Mortality and Atherosclerotic Morbidity. Metabolic Syndrome and Related Disorders. 3(2). 102–112. 11 indexed citations

20.

Schreyer, Sandra A., et al.. (2003). Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis. 171(1). 49–55. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact